On August 6, 2010, CME Group's Chief Regulatory Officer extended a summary access denial against Carmine Garofalo for an additional 60-day period. This action summarily denies Garofalo's access to all CME Group markets, including the CME Globex electronic trading platform, all trading floors owned or controlled by CME Group, and all clearing platforms owned or controlled by CME Group. The summary access denial prohibits Garofalo, a non-member Italian citizen residing in Tunisia, from trading, placing orders (for his own or someone else's behalf), or soliciting business on any exchange owned or controlled by CME Group, including NYMEX, CME, CBOT, and COMEX. Garofalo is also precluded from affiliating or doing business with any member or memeber firm at NYMEX, CME, CBOT, or COMEX.
This action is based on a good faith determination that there are substantial reasons to believe that such immediate action is necessary to protect the bext interests of the exchanges and their market participants.
Pursuant to Rule 413, this access denial will remain in effect for 60 days, beginning on August 6, 2010, and continuing through and including October 4, 2010.
August 6, 2010
This is an extension fo CME 10-06921-BC.
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.